CAR T Cell Therapies Program (ASGCT Pre-Annual Meeting Workshop)

When:  May 15, 2018 from 13:00 to 17:00 (CT)

The CAR T Therapies Program, presented by the American Society of Gene & Cell Therapy in collaboration with the Foundation for the Accreditation of Cellular Therapy, features discussions of the current state of CAR T therapeutic approaches in light of recent FDA approvals, including the establishment of immune effector programs and the challenges surrounding the implementation of commercial products. This program is part of the ASGCT Pre-Annual Workshops being held on May 15, 2018.  Visit the ASGCT 21st Annual Meeting registration page or download the CAR T Cell Therapies registration form

Welcome Introduction Remarks: 1 - 1:10 p.m.

Setting up an Immune Effector Program: 1:10 - 2:20 p.m.
In this session there will be talks describing different models for setting up immune effector programs either as stand-alone programs or as programs integrated with a hemopoietic stem cell transplant program. The resources required for financial co-ordination, care co-ordination, clinical care and data management will be discussed in different models covering both adult and pediatric patients.
Helen Heslop, MD and Sergio Giralt, MD
Helen Heslop, MD
Sergio Giralt, MD
EJ Shapall, MD
Samer Khaled, MD

Accreditation: 2:20 - 3 p.m.
Chair: Sarah Nikiforow, MD, PhD
Phyllis Warkentin, MD
Sarah Nikiforow, MD, PhD

Coffee Break: 3 - 3:30 p.m.

Implementing Commercial Products: 3:30 - 5 p.m.
In this session we will discuss the challenges of implementing commercial adoptive immunotherapy including practical considerations and our current understanding of the financial systems and potential barriers faced by patients and centers. 
Chair: Krishna Komanduri, MD
Stephanie Farnia, MPH
Krishna Komanduri, MD
Fred LeMaistre, MD
Fred Locke, MD



Hilton Chicago
720 S. Michigan Ave
Chicago, IL 60605